CIK 0000748592 · Non-accelerated filer<br>Smaller reporting company
Ernexa Therapeutics Inc.
Sign in to watch- Ticker
- ERNA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 311103425
- Phone
- (617) 798-6700
- Business address
- 1035 CAMBRIDGE STREET, SUITE 18A, CAMBRIDGE, MA, 02141
- Former names
- Eterna Therapeutics Inc., Brooklyn ImmunoTherapeutics, Inc., NTN BUZZTIME INC, NTN COMMUNICATIONS INC
Securities
- ERNA Common Stock Nasdaq
- ERNAW Warrants Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 89 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2014-09-08 | Gurrola Sandra M VP of Finance | Grant or award · Stock Options (Right to Buy) | +50,000 | 80,000 | ||
| 2014-06-10 | Uphoff Tony Director | Purchase | +9,600 | $0.52 | $5K | 9,600 |
| 2014-06-06 | Yanover Paul Director | Grant or award · Stock Options (Right to Buy) | +20,000 | 70,000 | ||
| 2014-06-06 | Uphoff Tony Director | Grant or award · Stock Options (Right to Buy) | +20,000 | 70,000 | ||
| 2014-06-06 | Mitgang Steve Director | Grant or award · Stock Options (Right to Buy) | +20,000 | 110,000 | ||
| 2014-06-06 | Lewis Mary Beth Director | Grant or award · Stock Options (Right to Buy) | +20,000 | 100,000 | ||
| 2014-05-12 | Thomas William SVP Marketing | Grant or award · Stock Options (Right to Buy) | +200,000 | 200,000 | ||
| 2014-05-05 | Khuchua Vladimir CHIEF DEVELOPMENT OFFICER | Grant or award · Stock Options (Right to Buy) | +75,000 | 350,000 | ||
| 2014-01-23 | Cooney Robert J Chief Operating Officer | Grant or award · Stock Options (Right to Buy) | +750,000 | 750,000 | ||
| 2013-06-13 | Yanover Paul Director | Grant or award · Stock Options (Right to Buy) | +20,000 | 50,000 | ||
| 2013-06-13 | Uphoff Tony Director | Grant or award · Stock Options (Right to Buy) | +20,000 | 50,000 | ||
| 2013-06-13 | Mitgang Steve Director | Grant or award · Stock Options (Right to Buy) | +20,000 | 90,000 | ||
| 2013-06-13 | Lewis Mary Beth Director | Grant or award · Stock Options (Right to Buy) | +20,000 | 80,000 | ||
| 2013-04-15 | Nagamine Kirk Chief Revenue Officer | Grant or award · Stock Options (Right to Buy) | +300,000 | 300,000 | ||
| 2013-04-08 | Khuchua Vladimir Chief Product Officer | Grant or award · Stock Options (Right to Buy) | +100,000 | 275,000 | ||
| 2013-03-20 | Uphoff Tony Director | Grant or award · Stock Options (Right to Buy) | +30,000 | 30,000 | ||
| 2013-01-31 | Chandler Barry Chief Marketing Officer | Grant or award | +250,000 | 250,000 | ||
| 2013-01-02 | Chandler Barry Chief Marketing Officer | Grant or award · Stock Options (Right to Buy) | +300,000 | 300,000 | ||
| 2012-12-18 | Berg Jeffrey Alan Interim CEO | Purchase | +3,458,629 | $0.20 | $692K | 20,575,887 |
| 2012-12-14 | Yanover Paul Director | Gift | +100,000 | 100,000 |
Page 23 of 33 · 657 trades